Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAT1A Antikörper

Der Kaninchen Polyklonal anti-MAT1A Antikörper (ABIN7881623) detektiert spezifisch MAT1A in WB, FACS und IF. Dieser Antikörper reagiert spezifisch mit Proben aus Human, Maus und Ratte.
Produktnummer ABIN7881623
644,88 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für MAT1A Antikörper (ABIN7881623)

Target

Alle MAT1A Antikörper anzeigen
MAT1A (Methionine Adenosyltransferase I, alpha (MAT1A))

Reaktivität

  • 57
  • 37
  • 36
  • 7
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 55
  • 2
Kaninchen

Klonalität

  • 45
  • 12
Polyklonal

Konjugat

  • 25
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser MAT1A Antikörper ist unkonjugiert

Applikation

  • 41
  • 18
  • 16
  • 10
  • 9
  • 6
  • 3
  • 2
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF)
  • Verwendungszweck

    MAT1A Antibody / Methionine adenosyltransferase 1

    Sequenz

    DYQRVVRDTI KHIGYDD

    Aufreinigung

    Antigen affinity purified

    Immunogen

    Amino acids DYQRVVRDTIKHIGYDD were used as the immunogen for the MAT1A antibody.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal dilution of the MAT1A antibody should be determined by the researcher.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Buffer

    0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    After reconstitution, the MAT1A antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
  • Target

    MAT1A (Methionine Adenosyltransferase I, alpha (MAT1A))

    Andere Bezeichnung

    Mat1a

    Hintergrund

    MAT1A antibody targets Methionine adenosyltransferase 1, encoded by the MAT1A gene. Methionine adenosyltransferase 1 is a cytosolic enzyme that catalyzes the formation of S-adenosylmethionine from methionine and ATP, representing the primary source of cellular methyl donor in adult liver tissue. MAT1A is the dominant methionine adenosyltransferase isoform in hepatocytes and plays a central role in regulating cellular methylation capacity and metabolic homeostasis.

    Functionally, Methionine adenosyltransferase 1 controls intracellular S-adenosylmethionine levels, thereby influencing DNA, RNA, protein, and lipid methylation reactions. Through regulation of methyl group availability, MAT1A indirectly modulates gene expression, chromatin structure, and signaling pathways linked to cellular growth and differentiation. A MAT1A antibody supports studies focused on methylation biology and liver-specific metabolic regulation.

    MAT1A expression is highly enriched in adult liver and is markedly reduced or replaced by alternative isoforms in fetal liver and non-hepatic tissues. This tissue-specific expression pattern reflects its role in maintaining differentiated hepatocyte function and metabolic stability. Methionine adenosyltransferase 1 can associate with regulatory proteins and metabolic pathways that coordinate amino acid metabolism with epigenetic and transcriptional control mechanisms.

    From a disease-relevance perspective, MAT1A has been extensively studied in liver disease and cancer biology. Reduced MAT1A expression or activity is associated with chronic liver disease, cirrhosis, and hepatocellular carcinoma, where disruption of S-adenosylmethionine homeostasis contributes to altered methylation and cellular transformation. MAT1A dysfunction has also been investigated in oxidative stress responses and metabolic imbalance, underscoring its importance in liver health and disease progression.

    At the molecular level, Methionine adenosyltransferase 1 functions as a multimeric enzyme complex and contains conserved catalytic domains required for substrate binding and enzymatic activity. Regulatory mechanisms, including redox state and post-translational modification, can influence enzyme activity and apparent behavior in biochemical assays without altering primary sequence. MAT1A antibody reagents support research applications focused on liver metabolism, methylation-dependent signaling, and disease-associated metabolic dysregulation, with NSJ Bioreagents providing reagents intended for research use.

    UniProt

    Q00266

    Pathways

    Mitotic G1-G1/S Phases, M Phase, Ribonucleoside Biosynthetic Process, Methionine Biosynthetic Process
Sie sind hier:
Chat with us!